Success Metrics

Active Trials

4(80%)

Phase Distribution

Ph phase_1

80%

Ph phase_2

20%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution5 total trials

Phase 1Safety & dosage

4(80.0%)

Phase 2Efficacy & side effects

1(20.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(5)

Detailed Status

Recruiting4

Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

N/A

Most Advanced

Phase 2

Trials by Phase

Phase 14 (80.0%)

Phase 21 (20.0%)

Trials by Status

recruiting480%

not_yet_recruiting120%

Recent Activity

4 active trials

Showing 5 of 5

recruitingphase_2

Study of ZG005 in Combination With Platinum-Based Chemotherapy in Participants With Advanced Biliary Tract Carcinoma

NCT07099547

recruitingphase_1

ZG006 and ZG005 in Participants With Small Cell Lung Cancer or Neuroendocrine Carcinoma

NCT07038096

recruitingphase_1

Study of ZG005 in Combination With Gecacitinib in Participants With Advanced Cervical Cancer

NCT07080216

not_yet_recruitingphase_1

Study of ZG005 in Combination With Gecacitinib and Chemotherapy for Participants With Advanced Solid Tumors

NCT07142837

recruitingphase_1

Study of ZG005 in Combination With Etoposide and Cisplatin in Participants With Advanced Neuroendocrine Carcinoma.

NCT06372626

Clinical Trials (5)

Showing 5 of 5 trials

NCT07099547Phase 2

Study of ZG005 in Combination With Platinum-Based Chemotherapy in Participants With Advanced Biliary Tract Carcinoma

Recruiting

NCT07038096Phase 1

ZG006 and ZG005 in Participants With Small Cell Lung Cancer or Neuroendocrine Carcinoma

Recruiting

NCT07080216Phase 1

Study of ZG005 in Combination With Gecacitinib in Participants With Advanced Cervical Cancer

Recruiting

NCT07142837Phase 1

Study of ZG005 in Combination With Gecacitinib and Chemotherapy for Participants With Advanced Solid Tumors

Not Yet Recruiting

NCT06372626Phase 1

Study of ZG005 in Combination With Etoposide and Cisplatin in Participants With Advanced Neuroendocrine Carcinoma.

Recruiting

All 5 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 5